Dissemin is shutting down on January 1st, 2025

Published in

Springer Nature [academic journals on nature.com], Leukemia, 7(36), p. 1720-1748, 2022

DOI: 10.1038/s41375-022-01620-2

Links

Tools

Export citation

Search in Google Scholar

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

Journal article published in 2022 by Rita Alaggio ORCID, Catalina Amador ORCID, Ioannis Anagnostopoulos ORCID, Ayoma D. Attygalle ORCID, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti ORCID, Govind Bhagat ORCID, Anita Maria Borges, Daniel Boyer ORCID, Mariarita Calaminici ORCID, Amy Chadburn ORCID, John K. C. Chan ORCID, Wah Cheuk ORCID, Wee-Joo Chng ORCID, John K. Choi ORCID and other authors.
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractWe herein present an overview of the upcoming 5th edition of the World Health Organization Classification of Haematolymphoid Tumours focussing on lymphoid neoplasms. Myeloid and histiocytic neoplasms will be presented in a separate accompanying article. Besides listing the entities of the classification, we highlight and explain changes from the revised 4th edition. These include reorganization of entities by a hierarchical system as is adopted throughout the 5th edition of the WHO classification of tumours of all organ systems, modification of nomenclature for some entities, revision of diagnostic criteria or subtypes, deletion of certain entities, and introduction of new entities, as well as inclusion of tumour-like lesions, mesenchymal lesions specific to lymph node and spleen, and germline predisposition syndromes associated with the lymphoid neoplasms.